文献速递垂体与肾上腺疾病

血清醛固酮的个体内变异及其对原发性醛固酮增多症筛查的意义

Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

在216例确诊原发性醛固酮增多症(PA)患者中,共进行671次醛固酮与直接肾素浓度(DRC)检测,醛固酮和醛固酮/直接肾素浓度比值(A/DRC)的个体内变异系数中位数分别为26.8%和26.7%。单次筛查假阴性率高,建议基于至少2次同时测定醛固酮和肾素的筛查。

要点

  • PA患者醛固酮个体内变异系数中位数为26.8%,A/DRC为26.7%。
  • 单次醛固酮检测以10 ng/dL为切点时PA筛查假阴性率为14.3%,2次检测降至4.6%。
  • A/DRC>2 ng/dL/µIU/mL时,基于1次和2次评估的PA诊断真阳性率分别为94.4%和98.4%。

核心结论

  • PA患者醛固酮浓度个体内变异高,导致单次筛查假阴性率升高;PA筛查应基于至少2次同时测定醛固酮和肾素的检测。

研究设计与样本

  • 在216例确诊PA且至少进行2次筛查的患者中,用相同的化学发光法进行671次醛固酮和DRC检测。

主要发现

  • 醛固酮和A/DRC的个体内变异系数中位数分别为26.8%和26.7%。
  • 近40%的患者至少一次醛固酮水平<15 ng/dL,19.9%至少2次<15 ng/dL,16.2%平均醛固酮<15 ng/dL。
  • 以10 ng/dL为切点时,单次醛固酮检测的PA筛查假阴性率为14.3%,2次检测为4.6%,平均醛固酮水平为2.3%。
  • 以最低醛固酮水平计,10 ng/dL和15 ng/dL阈值的真阳性率分别为85.7%和61.6%。
  • A/DRC>2 ng/dL/µIU/mL时,基于1次和2次评估的PA诊断真阳性率分别为94.4%和98.4%。

关键数值与推荐

  • PA筛查采用醛固酮/肾素比值升高且醛固酮最低水平10-15 ng/dL(277-415.5 pmol/L,免疫法)。
  • 以10 ng/dL为醛固酮切点时,单次检测PA筛查假阴性率为14.3%,2次检测为4.6%,平均醛固酮水平为2.3%。
  • 以最低醛固酮水平计,10 ng/dL和15 ng/dL阈值的真阳性率分别为85.7%和61.6%。
  • A/DRC>2 ng/dL/µIU/mL时,基于1次和2次评估的PA诊断真阳性率分别为94.4%和98.4%。

临床怎么用

  • PA筛查应基于至少2次同时测定醛固酮和肾素的检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary aldosteronism (PA) screening relies on an elevated aldosterone to renin ratio with a minimum aldosterone level, which varies from 10 to 15 ng/dL (277-415.5 pmol/L) using immunoassay. OBJECTIVE: To evaluate intra-individual coefficient of variation (CV) of aldosterone and aldosterone to direct renin concentration ratio (A/DRC) and its impact on PA screening. METHODS: A total of 671 aldosterone and DRC measurements were performed by the same chemiluminescence assays in a large cohort of 216 patients with confirmed PA and at least 2 screenings. RESULTS: The median intra-individual CV of aldosterone and A/DRC was 26.8% and 26.7%. Almost 40% of the patients had at least one aldosterone level <15 ng/dL, 19.9% had at least 2 aldosterone levels <15 ng/dL, and 16.2% had mean aldosterone levels <15 ng/dL. A lower cutoff of 10 ng/dL was associated with false negative rates for PA screening of 14.3% for a single aldosterone measurement, 4.6% for 2 aldosterone measurements, and only 2.3% for mean aldosterone levels. Considering the minimum aldosterone, true positive rate of aldosterone thresholds was 85.7% for 10 ng/dL and 61.6% for 15 ng/dL. An A/DRC >2 ng/dL/µIU/mL had a true positive rate for PA diagnosis of 94.4% and 98.4% when based on 1 or 2 assessments, respectively. CV of aldosterone and A/DRC were not affected by sex, use of interfering antihypertensive medications, PA lateralization, hypokalemia, age, and number of hormone measurements. CONCLUSION: Aldosterone concentrations had a high CV in PA patients, which results in an elevated rate of false negatives in a single screening for PA. Therefore, PA screening should be based on at least 2 screenings with concomitant aldosterone and renin measurements.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Maciel AAW, Freitas TC, Fagundes GFC, et al. Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening. J Clin Endocrinol Metab. 2023. PMID: 36413507. doi:10.1210/clinem/dgac679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。